Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Ultraviolet B-induced Otx2 expression in lens epithelial cells promotes epithelial-mesenchymal transition.

Yoshitomi Y, Osada H, Satake H, Kojima M, Saito-Takatsuji H, Ikeda T, Yoshitake Y, Ishigaki Y, Kubo E, Sasaki H, Yonekura H.

Biol Open. 2019 Feb 18;8(2). pii: bio035691. doi: 10.1242/bio.035691.

2.

Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis.

Yang F, Takagaki Y, Yoshitomi Y, Ikeda T, Li J, Kitada M, Kumagai A, Kawakita E, Shi S, Kanasaki K, Koya D.

Cancer Res. 2019 Feb 15;79(4):735-746. doi: 10.1158/0008-5472.CAN-18-0620. Epub 2018 Dec 24.

PMID:
30584072
3.

Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design.

Yasui T, Yamamoto T, Sakai N, Asano K, Takai T, Yoshitomi Y, Davis M, Takagi T, Sakamoto K, Sogabe S, Kamada Y, Lane W, Snell G, Iwata M, Goto M, Inooka H, Sakamoto JI, Nakada Y, Imaeda Y.

Bioorg Med Chem. 2017 Sep 1;25(17):4876-4886. doi: 10.1016/j.bmc.2017.07.037. Epub 2017 Jul 20.

PMID:
28760529
4.

Practical application of 3-substituted-2,6-difluoropyridines in drug discovery: Facile synthesis of novel protein kinase C theta inhibitors.

Katoh T, Tomata Y, Setoh M, Sasaki S, Takai T, Yoshitomi Y, Yukawa T, Nakagawa H, Fukumoto S, Tsukamoto T, Nakada Y.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2497-2501. doi: 10.1016/j.bmcl.2017.03.099. Epub 2017 Apr 2.

PMID:
28400232
5.

[The characteristics of social skills, school maladjustment and stress responses in junior high school students with autism spectrum disorder].

Okajima J, Kato N, Yoshitomi Y, Kanaya R, Sakuta R.

No To Hattatsu. 2017 Mar;49(2):120-5. Japanese.

PMID:
30113152
6.

JunB regulates angiogenesis and neurovascular parallel alignment in mouse embryonic skin.

Yoshitomi Y, Ikeda T, Saito H, Yoshitake Y, Ishigaki Y, Hatta T, Kato N, Yonekura H.

J Cell Sci. 2017 Mar 1;130(5):916-926. doi: 10.1242/jcs.196303. Epub 2017 Jan 17.

7.

Regulation of soluble Flt-1 (VEGFR-1) production by hnRNP D and protein arginine methylation.

Ikeda T, Yoshitomi Y, Saito H, Shimasaki T, Yamaya H, Kobata T, Ishigaki Y, Tomosugi N, Yoshitake Y, Yonekura H.

Mol Cell Biochem. 2016 Feb;413(1-2):155-64. doi: 10.1007/s11010-015-2649-y. Epub 2016 Jan 4.

PMID:
26728997
8.

Epiprofin orchestrates epidermal keratinocyte proliferation and differentiation.

Nakamura T, Yoshitomi Y, Sakai K, Patel V, Fukumoto S, Yamada Y.

J Cell Sci. 2014 Dec 15;127(Pt 24):5261-72. doi: 10.1242/jcs.156778. Epub 2014 Oct 24.

9.

Osteocytic cell necrosis is caused by a combination of glucocorticoid-induced Dickkopf-1 and hypoxia.

Ueda S, Ichiseki T, Yoshitomi Y, Yonekura H, Ueda Y, Kaneuji A, Matsumoto T.

Med Mol Morphol. 2015 Jun;48(2):69-75. doi: 10.1007/s00795-014-0077-9. Epub 2014 May 13.

PMID:
24819581
10.

Dietary deprivation of each essential amino acid induces differential systemic adaptive responses in mice.

Kamata S, Yamamoto J, Kamijo K, Ochiai T, Morita T, Yoshitomi Y, Hagiya Y, Kubota M, Ohkubo R, Kawaguchi M, Himi T, Kasahara T, Ishii I.

Mol Nutr Food Res. 2014 Jun;58(6):1309-21. doi: 10.1002/mnfr.201300758. Epub 2014 Feb 24.

PMID:
24668850
11.

Effectiveness of the direct renin inhibitor, aliskiren, in patients with resistant hypertension.

Yoshitomi Y, Kawanishi K, Yamaguchi A, Sakurai S, Minai K, Ishii T, Tarutani Y, Tsujibayashi T, Kaneki M, Saitou Y, Suwa S.

Int Heart J. 2013;54(2):88-92.

12.

Hypoxia down-regulates sFlt-1 (sVEGFR-1) expression in human microvascular endothelial cells by a mechanism involving mRNA alternative processing.

Ikeda T, Sun L, Tsuruoka N, Ishigaki Y, Yoshitomi Y, Yoshitake Y, Yonekura H.

Biochem J. 2011 Jun 1;436(2):399-407. doi: 10.1042/BJ20101490.

13.

Role of Epiprofin, a zinc-finger transcription factor, in limb development.

Talamillo A, Delgado I, Nakamura T, de-Vega S, Yoshitomi Y, Unda F, Birchmeier W, Yamada Y, Ros MA.

Dev Biol. 2010 Jan 15;337(2):363-74. doi: 10.1016/j.ydbio.2009.11.007. Epub 2009 Nov 10.

14.

Significance of pulsatility of brachial artery pressure for blood pressure control.

Yoshitomi Y, Ishii T, Tsujibayashi T, Kaneki M, Sakurai S.

Int Heart J. 2008 May;49(3):295-302.

15.

Matrix metalloproteinase-9 associated with heparan sulphate chains of GPI-anchored cell surface proteoglycans mediates motility of murine colon adenocarcinoma cells.

Koyama Y, Naruo H, Yoshitomi Y, Munesue S, Kiyono S, Kusano Y, Hashimoto K, Yokoi T, Nakanishi H, Shimizu S, Okayama M, Oguri K.

J Biochem. 2008 May;143(5):581-92. doi: 10.1093/jb/mvn006. Epub 2008 Jan 23.

PMID:
18216069
16.

A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis.

Munesue S, Yoshitomi Y, Kusano Y, Koyama Y, Nishiyama A, Nakanishi H, Miyazaki K, Ishimaru T, Miyaura S, Okayama M, Oguri K.

J Biol Chem. 2007 Sep 21;282(38):28164-74. Epub 2007 Jul 10.

17.
18.

Efficacy of a low dose of pitavastatin compared with atorvastatin in primary hyperlipidemia: results of a 12-week, open label study.

Yoshitomi Y, Ishii T, Kaneki M, Tsujibayashi T, Sakurai S, Nagakura C, Miyauchi A.

J Atheroscler Thromb. 2006 Apr;13(2):108-13.

19.

Significance of mean blood pressure for blood pressure control.

Yoshitomi Y, Nagakura C, Miyauchi A.

Int Heart J. 2005 Jul;46(4):691-9.

20.

Relation of pulsatility of brachial artery pressure to resistant hypertension.

Yoshitomi Y, Nagakura C, Miyauchi A.

Hypertens Res. 2004 Sep;27(9):641-6.

21.

Relationship between insulin resistance and effect of atorvastatin in non-diabetic subjects.

Yoshitomi Y, Ishii T, Kaneki M, Tsujibayashi T, Sakurai S, Nagakura C, Miyauchi A.

J Atheroscler Thromb. 2005;12(1):9-13.

22.

Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity.

Yoshitomi Y, Nakanishi H, Kusano Y, Munesue S, Oguri K, Tatematsu M, Yamashina I, Okayama M.

Cancer Lett. 2004 Apr 30;207(2):165-74.

PMID:
15072825
23.
24.

Related factors of meeting National Cholesterol Education Program-recommended goals with atorvastatin.

Yoshitomi Y, Tsujibayashi T, Ishii T, Sakurai S, Nagakura C, Miyauchi A; National Cholesterol Education Program.

J Atheroscler Thromb. 2003;10(1):19-24.

25.

Peristent tissue proliferation of multilink stents is dependent on preprocedural plaque area: a serial intravascular ultrasound analysis.

Yoshitomi Y, Kojima S, Yano M, Matsumoto Y, Sugi T, Saotome M, Tanaka KE, Endo M, Kuramochi M.

Angiology. 2002 May-Jun;53(3):303-11.

PMID:
12025918
26.

Primary cardiac lymphoma--a case report.

Saotome M, Yoshitomi Y, Kojima S, Kuramochi M.

Angiology. 2002 Mar-Apr;53(2):239-41.

PMID:
11952118
27.

The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones.

Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M.

Biochem J. 2002 Apr 15;363(Pt 2):201-9.

28.

Does stent design affect probability of restenosis? A randomized trial comparing Multilink stents with GFX stents.

Yoshitomi Y, Kojima S, Yano M, Sugi T, Matsumoto Y, Saotome M, Tanaka K, Endo M, Kuramochi M.

Am Heart J. 2001 Sep;142(3):445-51.

PMID:
11526357
29.

Dilated cardiomyopathy of Becker-type muscular dystrophy with exon 4 deletion--a case report.

Saotome M, Yoshitomi Y, Kojima S, Kuramochi M.

Angiology. 2001 May;52(5):343-7.

PMID:
11386386
31.

Relation between stent expansion and arterial remodeling: a serial intravascular ultrasound study.

Yoshitomi Y, Kojima S, Yano M, Matsumoto Y, Sugi T, Saotome M, Tanaka K, Endo M, Kuramochi M.

Catheter Cardiovasc Interv. 2000 Jul;50(3):282-9.

PMID:
10878623
32.

Heterogeneity of renal cortical circulation in hypertension assessed by dynamic computed tomography.

Kojima S, Yoshitomi Y, Yano M, Saotome M, Tanaka K, Endo M, Kuramochi M.

Am J Hypertens. 2000 Apr;13(4 Pt 1):346-52.

PMID:
10821334
33.

Long-term follow-up of primary stenting with coil stent in acute myocardial infarction.

Yano M, Yoshitomi Y, Kojima S, Sugi T, Matsumoto Y, Kuramochi M.

Angiology. 2000 Feb;51(2):107-14.

PMID:
10701718
34.
35.

Effects of losartan on low-density lipoprotein apheresis.

Kojima S, Yoshitomi Y, Saotome M, Tanaka K, Shida M, Kuramochi M.

Ther Apher. 1999 Nov;3(4):303-6.

PMID:
10608722
36.

[Usefulness of chloride serum concentrations in being treated with potassium bromide].

Matsufuji H, Nishikawa M, Yoshitomi Y, Ichiyama T, Hayashi T, Furukawa S.

No To Hattatsu. 1999 Sep;31(5):465-6. Japanese. No abstract available.

PMID:
10576780
37.
38.

Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease.

Yoshitomi Y, Kojima S, Umemoto T, Kubo K, Matsumoto Y, Yano M, Sugi T, Kuramochi M.

J Clin Endocrinol Metab. 1999 Jul;84(7):2425-8.

PMID:
10404815
39.

Benefit of intravascular ultrasound in Wiktor stent implantation.

Yoshitomi Y, Kojima S, Yano M, Sugi T, Matsumoto Y, Kuramochi M.

Catheter Cardiovasc Interv. 1999 May;47(1):28-35.

PMID:
10385154
40.

Changes in plasma levels of cyclic nucleotides during low-density lipoprotein apheresis.

Kojima S, Yoshitomi Y, Sugi T, Matsumoto Y, Yano M, Kuramochi M.

Ther Apher. 1998 Nov;2(4):263-7.

PMID:
10227752
41.

Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis.

Kojima S, Ogi M, Sugi T, Matsumoto Y, Yoshitomi Y, Kuramochi M.

Ther Apher. 1997 Nov;1(4):356-61.

PMID:
10225731
42.

Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction.

Nagaya N, Nishikimi T, Uematsu M, Yoshitomi Y, Miyao Y, Miyazaki S, Goto Y, Kojima S, Kuramochi M, Matsuo H, Kangawa K, Nonogi H.

Heart. 1999 May;81(5):483-7.

43.

Echocardiography of a right atrial mass in hepatocellular carcinoma.

Yoshitomi Y, Kojima S, Sugi T, Matsumoto Y, Yano M, Ozeki Y, Kuramochi M.

Heart Vessels. 1998;13(1):45-8.

PMID:
9923565
44.

Antiplatelet treatment with cilostazol after stent implantation.

Yoshitomi Y, Kojima S, Sugi T, Yano M, Matsumoto Y, Kuramochi M.

Heart. 1998 Oct;80(4):393-6.

45.

Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction.

Yoshitomi Y, Nishikimi T, Kojima S, Kuramochi M, Takishita S, Kangawa K, Matsuo H.

Int J Cardiol. 1998 Apr 1;64(2):153-60.

PMID:
9688434
46.

Progressive renal failure in POEMS syndrome.

Yoshitomi Y, Kawano Y, Kojima S, Murakami K, Matsuoka H, Imakita M, Yutani C, Omae T.

Nephron. 1998;79(3):377-8. No abstract available.

PMID:
9678455
47.

Coronary vasoreactivity to ergonovine after angioplasty: difference between the infarct-related coronary artery and the noninfarct-related coronary artery.

Yoshitomi Y, Kojima S, Sugi T, Matsumoto Y, Yano M, Kuramochi M.

Coron Artery Dis. 1998;9(2-3):105-11.

PMID:
9647411
48.

Acute renal failure in accidental hypothermia of cold water immersion.

Yoshitomi Y, Kojima S, Ogi M, Kuramochi M.

Am J Kidney Dis. 1998 May;31(5):856-9.

PMID:
9590198
49.

Plasma levels of adrenomedullin in patients with acute myocardial infarction.

Yoshitomi Y, Nishikimi T, Kojima S, Kuramochi M, Takishita S, Matsuoka H, Miyata A, Matsuo H, Kangawa K.

Clin Sci (Lond). 1998 Feb;94(2):135-9.

PMID:
9536921
50.

Supplemental Content

Loading ...
Support Center